{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:38:08Z","timestamp":1790203088009,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancertreatmentreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ctrv.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T06:55:18Z","timestamp":1438412118000},"page":"836-843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["The role of systemic therapy in the management of sinonasal cancer: A critical review"],"prefix":"10.1016","volume":"41","author":[{"given":"Paolo","family":"Bossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil F.","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan B.","family":"Vermorken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primoz","family":"Strojan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco","family":"de Bree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab Y.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Missak","family":"Haigentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Takes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet J.","family":"Slootweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Rinaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfio","family":"Ferlito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2015.07.004_b0005","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/hed.21830","article-title":"Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data","volume":"34","author":"Turner","year":"2012","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.ctrv.2015.07.004_b0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00405-012-2025-4","article-title":"Sinonasal tumors: a clinicopathologic update of selected tumors","volume":"270","author":"Slootweg","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"14","key":"10.1016\/j.ctrv.2015.07.004_b0015","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1002\/cncr.28108","article-title":"Paranasal sinus squamous cell carcinoma incidence and survival based on surveillance, epidemiology, and end results data, 1973 to 2009","volume":"119","author":"Ansa","year":"2013","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2015.07.004_b0020","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1365-2559.2011.03813.x","article-title":"Current diagnostic strategies for undifferentiated tumours of the nasal cavities and paranasal sinuses","volume":"59","author":"Franchi","year":"2011","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.ctrv.2015.07.004_b0025","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.pas.0000173240.63073.fe","article-title":"Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract. A distinct clinicopathologic and molecular disease entity","volume":"29","author":"El-Mofty","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.ctrv.2015.07.004_b0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PAP.0b013e3181e3bf80","article-title":"Adenocarcinoma of the upper aerodigestive tract","volume":"17","author":"Stelow","year":"2010","journal-title":"Adv Anat Pathol"},{"issue":"9","key":"10.1016\/j.ctrv.2015.07.004_b0035","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0278-2391(03)00313-6","article-title":"Factors affecting survival in maxillary sinus cancer","volume":"61","author":"Bhattacharyya","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"10.1016\/j.ctrv.2015.07.004_b0040","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/bjc.1987.303","article-title":"Tobacco use and sinonasal cancer: a case-control study","volume":"56","author":"Hayes","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2015.07.004_b0045","article-title":"Update on primary head and neck mucosal melanoma","author":"Lopez","year":"2014","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.ctrv.2015.07.004_b0050","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/modpathol.2008.57","article-title":"Array comparative genomic hybridization analysis of olfactory neuroblastoma","volume":"21","author":"Guled","year":"2008","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.ctrv.2015.07.004_b0055","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.oraloncology.2015.04.005","article-title":"Adenoid cystic carcinoma of the head and neck \u2013 an update","volume":"51","author":"Coca-Pelaz","year":"2015","journal-title":"Oral Oncol"},{"issue":"13","key":"10.1016\/j.ctrv.2015.07.004_b0060","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1158\/0008-5472.CAN-15-0340","article-title":"High-frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma","volume":"75","author":"Udager","year":"2015","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ctrv.2015.07.004_b0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hed.23267","article-title":"Molecular profiling of sinonasal undifferentiated carcinoma","volume":"36","author":"Gelbard","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.ctrv.2015.07.004_b0070","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrclinonc.2014.97","article-title":"Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances","volume":"11","author":"Llorente","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11912-013-0369-6","article-title":"Endoscopic resection of sinonasal cancers","volume":"16","author":"Su","year":"2014","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ctrv.2015.07.004_b0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/0194599811403873","article-title":"Ethmoid adenocarcinoma \u2013 From craniofacial to endoscopic resections: a single-institution experience over 25years","volume":"145","author":"Nicolai","year":"2011","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ctrv.2015.07.004_b0085","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijrobp.2011.06.1977","article-title":"IMRT for sinonasal tumors minimizes severe late ocular toxicity and preserves disease control and survival","volume":"83","author":"Duprez","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2015.07.004_b0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2013.11.010","article-title":"Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis","volume":"110","author":"Marta","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0095","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.otc.2011.08.012","article-title":"Proton beam therapy in skull base pathology","volume":"44","author":"Alonso-Basanta","year":"2011","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.ctrv.2015.07.004_b0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1748-717X-6-30","article-title":"Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity","volume":"6","author":"Jensen","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0105","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2015.07.004_b0110","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2015.07.004_b0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(13)70011-1","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial","volume":"14","author":"Haddad","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0120","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2013.54.6309","article-title":"Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer","volume":"32","author":"Cohen","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(19880701)62:1<1::AID-CNCR2820620102>3.0.CO;2-F","article-title":"Chemotherapy for paranasal sinus carcinoma: a 10-year experience at Wayne State University","volume":"62","author":"LoRusso","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2015.07.004_b0130","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/1097-0142(19921201)70:11<2615::AID-CNCR2820701108>3.0.CO;2-G","article-title":"Potential impact on tumor control and organ preservation with cisplatin and 5FU for patients with advanced tumors of the paranasal sinuses and nasal fossa. A prospective pilot study","volume":"70","author":"Bjork-Eriksson","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2015.07.004_b0135","first-page":"219","article-title":"Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results","volume":"5","author":"Lee","year":"1999","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.ctrv.2015.07.004_b0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/annonc\/mdg113","article-title":"Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer","volume":"14","author":"Licitra","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archoto.2010.231","article-title":"Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses","volume":"137","author":"Hanna","year":"2011","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ctrv.2015.07.004_b0150","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ijrobp.2008.01.038","article-title":"Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities","volume":"72","author":"Hoppe","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2015.07.004_b0155","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.joms.2011.06.221","article-title":"Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy and\/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis","volume":"70","author":"Kang","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ctrv.2015.07.004_b0160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejso.2006.10.033","article-title":"Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients","volume":"33","author":"Guntinas-Lichius","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0165","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/lary.20196","article-title":"Carcinoma of the nasal cavity and paranasal sinuses","volume":"119","author":"Mendenhall","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ctrv.2015.07.004_b0170","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/cncr.11771","article-title":"Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma","volume":"98","author":"Papadimitrakopoulou","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2015.07.004_b0175","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/archotol.130.8.948","article-title":"Intra-arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer","volume":"130","author":"Samant","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ctrv.2015.07.004_b0180","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1002\/cncr.24515","article-title":"Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience","volume":"115","author":"Homma","year":"2009","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ctrv.2015.07.004_b0185","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1038\/bjc.2013.663","article-title":"Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer","volume":"109","author":"Homma","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2015.07.004_b0190","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.oraloncology.2012.12.011","article-title":"Tp53 status as guide for the management of ethmoid sinus intestinal-type adenocarcinoma","volume":"49","author":"Bossi","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0195","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer","volume":"324","author":"The Department of Veterans Affairs Laryngeal Cancer Study Group","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2015.07.004_b0200","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1200\/JCO.2012.42.3988","article-title":"Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study","volume":"31","author":"Lefebvre","year":"2013","journal-title":"J Clin Oncol"},{"issue":"349","key":"10.1016\/j.ctrv.2015.07.004_b0205","doi-asserted-by":"crossref","first-page":"g6802","DOI":"10.1136\/bmj.g6802","article-title":"Innovative research methods for studying treatments for rare diseases: methodological review","volume":"24","author":"Gagne","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ctrv.2015.07.004_b0210","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1200\/JCO.2004.05.071","article-title":"Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma","volume":"22","author":"Licitra","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archotol.127.2.141","article-title":"Adenocarcinoma of the ethmoidal sinus complex: surgical debulking and topical fluorouracil may be the optimal treatment","volume":"127","author":"Knegt","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ctrv.2015.07.004_b0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0194599812440932","article-title":"Meta analysis of treatment outcomes for sinonasal undifferentiated carcinoma","volume":"147","author":"Reiersen","year":"2012","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ctrv.2015.07.004_b0225","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/00005537-200208000-00023","article-title":"Sinonasal undifferentiated carcinoma: the search for a better outcome","volume":"112","author":"Musy","year":"2002","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ctrv.2015.07.004_b0230","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hed.10396","article-title":"Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma","volume":"26","author":"Rischin","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.ctrv.2015.07.004_b0235","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/COC.0b013e31825eb3a5","article-title":"Trimodality management of sinonasal undifferentiated carcinoma and review of the literature","volume":"36","author":"Mourad","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0240","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/cncr.20693","article-title":"Sinonasal malignancies with neuroendocrine differentiation. Patterns of failure according to histologic phenotype","volume":"101","author":"Rosenthal","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2015.07.004_b0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1758-3284-3-32","article-title":"Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome","volume":"3","author":"Likhacheva","year":"2011","journal-title":"Head Neck Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0250","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1002\/cncr.10537","article-title":"Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery and combined proton-photon radiotherapy","volume":"94","author":"Fitzek","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2015.07.004_b0255","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00405-013-2554-5","article-title":"The importance of multimodality therapy in the treatment of sinonasal neuroendocrine carcinoma","volume":"270","author":"Van der Laan","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0260","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/archotol.132.2.134","article-title":"Esthesioneuroblastoma: continued follow-up of a single institution\u2019s experience","volume":"132","author":"Loy","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ctrv.2015.07.004_b0265","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.amjoto.2003.12.002","article-title":"Sinonasal undifferentiated carcinoma: case series and literature review","volume":"25","author":"Kim","year":"2004","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0270","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00006123-199805000-00040","article-title":"Chemotherapy for advanced esthesioneuroblastoma: the Mayo clinic experience","volume":"42","author":"McElroy","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ctrv.2015.07.004_b0275","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11060-008-9645-y","article-title":"Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma","volume":"90","author":"Porter","year":"2008","journal-title":"J Neuroncol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.07.004_b0280","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12105-014-0547-3","article-title":"Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes","volume":"9","author":"Bell","year":"2015","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0285","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/hed.23327","article-title":"Optimization of long-term outcomes for patients with esthesioneuroblastoma","volume":"36","author":"Ow","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.ctrv.2015.07.004_b0290","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/hed.21340","article-title":"Outcome of sinonasal melanoma: clinical experience and review of the literature","volume":"32","author":"Roth","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.ctrv.2015.07.004_b0295","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0032-1301400","article-title":"Survival in sinonasal melanomas: a meta-analysis","volume":"73","author":"Gore","year":"2012","journal-title":"J Neurol Surg B Skull Base"},{"key":"10.1016\/j.ctrv.2015.07.004_b0300","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/hed.20910","article-title":"Biochemotherapy in patients with advanced head and neck mucosal melanoma","volume":"30","author":"Bartell","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.ctrv.2015.07.004_b0305","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1200\/JCO.2007.12.0253","article-title":"Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2.621 patients","volume":"25","author":"Ives","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0310","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/07357900802027073","article-title":"Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma","volume":"26","author":"Bedikian","year":"2008","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ctrv.2015.07.004_b0315","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0028-1115321","article-title":"Sinonasal mucosal melanoma: a 13-year experience at a single institution","volume":"19","author":"Narasimhan","year":"2009","journal-title":"Skull Base"},{"key":"10.1016\/j.ctrv.2015.07.004_b0320","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1158\/1078-0432.CCR-13-0739","article-title":"Phase II randomized trial comparing high-dose IFN-\u03b12b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma","volume":"19","author":"Lian","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2015.07.004_b0325","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.humpath.2013.01.025","article-title":"Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations","volume":"44","author":"Chraybi","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0330","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2007.14.0707","article-title":"Major response to imatinib mesylate in KIT mutated melanoma","volume":"26","author":"Hodi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0335","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1517\/13543784.2013.837449","article-title":"The potential role of sunitinib targeting melanomas","volume":"22","author":"Valsecchi","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ctrv.2015.07.004_b0340","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1200\/JCO.2010.33.9275","article-title":"Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification","volume":"29","author":"Guo","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0345","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2012.47.7836","article-title":"Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun damaged skin","volume":"31","author":"Hodi","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0350","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejca.2013.09.007","article-title":"Efficacy and safety of ipilimumab 3mg\/kg in patients with pretreated, metastatic, mucosal melanoma","volume":"50","author":"Del Vecchio","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2015.07.004_b0355","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1158\/2326-6066.CIR-13-0146","article-title":"Anti-PD1 following ipilimumab for mucosal melanoma: durable tumor response associated with severe hypothyroidism and rhabdomyolysis","volume":"2","author":"Min","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ctrv.2015.07.004_b0360","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mpo.1259","article-title":"Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978\u20131997","volume":"38","author":"Raney","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0365","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0194-5998(95)70246-6","article-title":"Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children","volume":"112","author":"Callender","year":"1995","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ctrv.2015.07.004_b0370","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/annonc\/mdt126","article-title":"Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution","volume":"24","author":"Mattavelli","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0375","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ssu.2980100508","article-title":"Chemotherapeutic approaches to soft tissue sarcomas","volume":"10","author":"Edmonson","year":"1994","journal-title":"Sem Surg Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0380","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12105-009-0160-z","article-title":"The impact of advances in molecular genetic pathology on the classification, diagnosis and treatment of selected soft tissue tumors of the head and neck","volume":"4","author":"Garc\u00eda","year":"2010","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0385","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.critrevonc.2007.04.001","article-title":"Gene expression profiling in sarcomas","volume":"63","author":"Tschoep","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0390","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/alr.21162","article-title":"Management of sinonasal chondrosarcoma: a systematic review of 161 patients","volume":"3","author":"Khan","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0395","doi-asserted-by":"crossref","unstructured":"Van den Berg H, Schreuder WH, De Lange J. Osteosarcoma: a comparison of jaw versus nonjaw localizations and review of the literature. Sarcoma 2013; ID 316123.","DOI":"10.1155\/2013\/316123"},{"key":"10.1016\/j.ctrv.2015.07.004_b0400","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.oraloncology.2007.03.001","article-title":"Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study group","volume":"44","author":"Jasnau","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0405","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/cncr.26451","article-title":"Gene amplification and protein overexpression of EGFR and ERBB2 in sinonasal squamous cell carcinoma","volume":"118","author":"L\u00f3pez","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2015.07.004_b0410","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.oraloncology.2012.02.018","article-title":"KRAS and BRAF mutations in sinonasal cancer","volume":"48","author":"L\u00f3pez","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0415","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.humpath.2012.08.017","article-title":"Detection of human papillomavirus in sinonasal carcinoma: systematic review and meta-analysis","volume":"44","author":"Syrj\u00e4nen","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ctrv.2015.07.004_b0420","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/cncr.24309","article-title":"Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome","volume":"115","author":"Alos","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2015.07.004_b0425","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/modpathol.2013.155","article-title":"High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas","volume":"27","author":"Larque","year":"2014","journal-title":"Mod Pathol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737215001498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737215001498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:09:11Z","timestamp":1567037351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737215001498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":85,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0305737215001498"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2015.07.004","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of systemic therapy in the management of sinonasal cancer: A critical review","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}